{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:29:13Z","timestamp":1784042953123,"version":"3.55.0"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rheumatoid arthritis (RA) is a chronic systemic autoimmune disorder characterized by synovial joint inflammation, leading to progressive joint damage, deformity, and disability. The lungs are the most common site for extra-articular manifestation, and significant Interstitial lung disease can occur in one in ten RA patients, leading to a significant increase in disability and mortality. This puts a substantial strain on patients and healthcare resources. The current understanding of RA and its manifestations remains limited. This review article explores the currently available data and literature.<\/jats:p>","DOI":"10.1093\/qjmed\/hcaf260","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:15:49Z","timestamp":1761743749000},"page":"7-14","source":"Crossref","is-referenced-by-count":4,"title":["Rheumatoid arthritis-associated interstitial lung disease: an overview"],"prefix":"10.1093","volume":"119","author":[{"given":"Khaled","family":"Musameh","sequence":"first","affiliation":[{"name":"Discipline of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"Respiratory Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5009-9350","authenticated-orcid":false,"given":"Shane Peter","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Discipline of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"Respiratory Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Butler","sequence":"additional","affiliation":[{"name":"Discipline of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Buckley","sequence":"additional","affiliation":[{"name":"Radiology Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Noone","sequence":"additional","affiliation":[{"name":"Radiology Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh","family":"Halpenny","sequence":"additional","affiliation":[{"name":"Radiology Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-9618","authenticated-orcid":false,"given":"Patrick","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Discipline of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"Respiratory Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Discipline of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"El Obeid","sequence":"additional","affiliation":[{"name":"Discipline of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"Respiratory Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamas C","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Discipline of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght University Hospital , Dublin,","place":["Ireland"]},{"name":"Respiratory Department, Tallaght University Hospital , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2026022011472288100_hcaf260-B1","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"Black","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026022011472288100_hcaf260-B2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"key":"2026022011472288100_hcaf260-B3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1185\/03007990903422307","article-title":"Societal cost of rheumatoid arthritis patients in the US","volume":"26","author":"Birnbaum","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"2026022011472288100_hcaf260-B4","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s10198-007-0088-8","article-title":"The burden of rheumatoid arthritis and access to treatment: health burden and costs","volume":"8 Suppl 2","author":"Lundkvist","year":"2008","journal-title":"Eur J Health Econ"},{"key":"2026022011472288100_hcaf260-B5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B6","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/rheumatology\/kead106","article-title":"Mortality estimates and excess mortality in rheumatoid arthritis","volume":"62","author":"Black","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026022011472288100_hcaf260-B7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejim.2013.07.004","article-title":"Rheumatoid arthritis (RA) associated interstitial lung disease (ILD)","volume":"24","author":"O'Dwyer","year":"2013","journal-title":"Eur J Intern Med"},{"key":"2026022011472288100_hcaf260-B8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","article-title":"Cigarette smoking and rheumatoid arthritis severity","volume":"56","author":"Saag","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"2026022011472288100_hcaf260-B9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"key":"2026022011472288100_hcaf260-B10","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford"},{"key":"2026022011472288100_hcaf260-B11","doi-asserted-by":"crossref","first-page":"00633","DOI":"10.1183\/23120541.00633-2020","article-title":"Duration of rheumatoid arthritis and the risk of developing interstitial lung disease","volume":"7","author":"Mohning","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026022011472288100_hcaf260-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw","year":"2015","journal-title":"Eur Respir Rev"},{"key":"2026022011472288100_hcaf260-B13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026022011472288100_hcaf260-B14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B15","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.rdc.2010.02.001","article-title":"Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation","volume":"36","author":"Deane","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"2026022011472288100_hcaf260-B17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/thorax-2023-220856","article-title":"Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study","volume":"79","author":"Leavy","year":"2024","journal-title":"Thorax"},{"key":"2026022011472288100_hcaf260-B18","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/jcm13206080","article-title":"Multi-ancestry causal association between rheumatoid arthritis and interstitial lung disease: a bidirectional two-sample mendelian randomization study","volume":"13","author":"Kim","year":"2024","journal-title":"J Clin Med"},{"key":"2026022011472288100_hcaf260-B19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2026022011472288100_hcaf260-B20","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/art.39771","article-title":"Elevated IgA plasmablast levels in subjects at risk of developing rheumatoid arthritis","volume":"68","author":"Kinslow","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026022011472288100_hcaf260-B21","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2026022011472288100_hcaf260-B22","doi-asserted-by":"crossref","first-page":"1526881","DOI":"10.3389\/fimmu.2025.1526881","article-title":"Increased sputum peripheral helper T cells are associated with the severity of rheumatoid arthritis but not with the severity of airway disease","volume":"16","author":"Yokoi","year":"2025","journal-title":"Front Immunol"},{"key":"2026022011472288100_hcaf260-B23","first-page":"7262065","article-title":"Risk factors and changes of peripheral NK and T cells in pulmonary interstitial fibrosis of patients with rheumatoid arthritis","volume":"2019","author":"Lai","year":"2019","journal-title":"Can Respir J"},{"key":"2026022011472288100_hcaf260-B24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8","article-title":"The genetics revolution and the assault on rheumatoid arthritis","volume":"42","author":"Seldin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B26","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2026022011472288100_hcaf260-B27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3899\/jrheum.090303","article-title":"HLA-DRB1 alleles and rheumatoid arthritis-related pulmonary fibrosis","volume":"37","author":"Migita","year":"2010","journal-title":"J Rheumatol"},{"key":"2026022011472288100_hcaf260-B28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/03009742.2013.841284","article-title":"HLA-DRB1 associations with rheumatoid arthritis-related pulmonary fibrosis","volume":"43","author":"Ennis","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"2026022011472288100_hcaf260-B29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00408-016-9916-x","article-title":"Association of single nucleotide polymorphisms of PADI4 and HLA-DRB1 alleles with susceptibility to rheumatoid arthritis-related lung diseases","volume":"194","author":"Song","year":"2016","journal-title":"Lung"},{"key":"2026022011472288100_hcaf260-B30","doi-asserted-by":"crossref","first-page":"e33133","DOI":"10.1371\/journal.pone.0033133","article-title":"Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope","volume":"7","author":"Furukawa","year":"2012","journal-title":"PLoS One"},{"key":"2026022011472288100_hcaf260-B31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2026022011472288100_hcaf260-B32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/rheumatology\/ken005","article-title":"Recent advances in the genetics of RA susceptibility","volume":"47","author":"Bowes","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2026022011472288100_hcaf260-B33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"2026022011472288100_hcaf260-B34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/thoraxjnl-2012-201786","article-title":"Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis","volume":"68","author":"Stock","year":"2013","journal-title":"Thorax"},{"key":"2026022011472288100_hcaf260-B35","doi-asserted-by":"crossref","first-page":"1602314","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"key":"2026022011472288100_hcaf260-B36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/art.43113","article-title":"Associations of fire smoke and other pollutants with incident rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease","volume":"77","author":"Kronzer","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"2026022011472288100_hcaf260-B37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/annrheumdis-2012-201587","article-title":"Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study","volume":"72","author":"Hart","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026022011472288100_hcaf260-B38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.2004.022053","article-title":"Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"64","author":"Stolt","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2026022011472288100_hcaf260-B39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejim.2010.02.004","article-title":"Rheumatoid pneumoconiosis (Caplan\u2019s syndrome)","volume":"21","author":"Schreiber","year":"2010","journal-title":"Eur J Intern Med"},{"key":"2026022011472288100_hcaf260-B40","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"2026022011472288100_hcaf260-B41","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/jcm8122038","article-title":"Interstitial lung disease in rheumatoid arthritis remains a challenge for clinicians","volume":"8","author":"Bendstrup","year":"2019","journal-title":"J Clin Med"},{"key":"2026022011472288100_hcaf260-B42","doi-asserted-by":"crossref","first-page":"1800869","DOI":"10.1183\/13993003.00869-2018","article-title":"Predicting outcomes in rheumatoid arthritis related interstitial lung disease","volume":"53","author":"Jacob","year":"2019","journal-title":"Eur Respir J"},{"key":"2026022011472288100_hcaf260-B43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.20765","article-title":"Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis","volume":"52","author":"Turesson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780330601","article-title":"The rheumatoid nodule","volume":"33","author":"Ziff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B45","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJMoa1007285","article-title":"Lung volumes and emphysema in smokers with interstitial lung abnormalities","volume":"364","author":"Washko","year":"2011","journal-title":"N Engl J Med"},{"key":"2026022011472288100_hcaf260-B46","doi-asserted-by":"crossref","first-page":"00035","DOI":"10.1183\/23120541.00035-2023","article-title":"High prevalence of interstitial lung abnormalities in middle-aged never-smokers","volume":"9","author":"Pesonen","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026022011472288100_hcaf260-B47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.13120816","article-title":"Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate","volume":"268","author":"Jin","year":"2013","journal-title":"Radiology"},{"key":"2026022011472288100_hcaf260-B48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201809-1652OC","article-title":"Imaging patterns are associated with interstitial lung abnormality progression and mortality","volume":"200","author":"Putman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022011472288100_hcaf260-B49","doi-asserted-by":"crossref","first-page":"200223","DOI":"10.1183\/20734735.0223-2020","article-title":"Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what\u2019s new","volume":"16","author":"Leone","year":"2020","journal-title":"Breathe (Sheff)"},{"key":"2026022011472288100_hcaf260-B50","doi-asserted-by":"crossref","first-page":"Si286","DOI":"10.1093\/rheumatology\/kead277","article-title":"Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers","volume":"62","author":"McDermott","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2026022011472288100_hcaf260-B51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurjrheum.2019.19044","article-title":"Interstitial lung abnormalities in patients with early rheumatoid arthritis: a pilot study evaluating prevalence and progression","volume":"6","author":"Dong","year":"2019","journal-title":"Eur J Rheumatol"},{"key":"2026022011472288100_hcaf260-B52","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2026022011472288100_hcaf260-B53","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"key":"2026022011472288100_hcaf260-B54","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.rmed.2012.04.004","article-title":"Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases","volume":"106","author":"Nakamura","year":"2012","journal-title":"Respir Med"},{"key":"2026022011472288100_hcaf260-B55","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","article-title":"Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"107","author":"Solomon","year":"2013","journal-title":"Respir Med"},{"key":"2026022011472288100_hcaf260-B56","first-page":"450","article-title":"Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis","volume":"133","author":"Garcia","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"2026022011472288100_hcaf260-B57","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201508-1632OC","article-title":"In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011","volume":"193","author":"Hutchinson","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022011472288100_hcaf260-B58","doi-asserted-by":"crossref","first-page":"e000935","DOI":"10.1136\/rmdopen-2019-000935","article-title":"Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study","volume":"5","author":"Mehta","year":"2019","journal-title":"RMD Open"},{"key":"2026022011472288100_hcaf260-B59","article-title":"Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: a comparative cohort study","author":"Zhang","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"2026022011472288100_hcaf260-B60","first-page":"243","article-title":"Drug-induced pneumonitis: the role of methotrexate","volume":"18","author":"Zisman","year":"2001","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026022011472288100_hcaf260-B61","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026022011472288100_hcaf260-B62","doi-asserted-by":"crossref","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"2026022011472288100_hcaf260-B63","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2026022011472288100_hcaf260-B64","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis","volume":"36","author":"Rojas-Serrano","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2026022011472288100_hcaf260-B65","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archinte.168.15.1718","article-title":"Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug","volume":"168","author":"Saketkoo","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026022011472288100_hcaf260-B66","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J Rheumatol"},{"key":"2026022011472288100_hcaf260-B67","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/jcm9041082","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease: lights and shadows","volume":"9","author":"Cassone","year":"2020","journal-title":"J Clin Med"},{"key":"2026022011472288100_hcaf260-B68","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"2026022011472288100_hcaf260-B69","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pds.3409","article-title":"Association between anti-TNF-\u03b1 therapy and interstitial lung disease","volume":"22","author":"Herrinton","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026022011472288100_hcaf260-B70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/annrheumdis-2011-200170","article-title":"Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE","volume":"71","author":"Tak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2026022011472288100_hcaf260-B71","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/annrheumdis-2012-201956","article-title":"Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients","volume":"72","author":"van Vollenhoven","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026022011472288100_hcaf260-B72","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","article-title":"Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years\u2019 experience at a single centre","volume":"56","author":"Md Yusof","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026022011472288100_hcaf260-B73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4236\/ojra.2012.23011","article-title":"Open-label, pilot study of the safety and clinical effects of rituximab in patients with rheumatoid arthritis-associated interstitial pneumonia","volume":"02","author":"Matteson","year":"2012","journal-title":"OJRA"},{"key":"2026022011472288100_hcaf260-B74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imj.14306","article-title":"Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis","volume":"50","author":"Fui","year":"2020","journal-title":"Intern Med J"},{"key":"2026022011472288100_hcaf260-B75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2213-2600(22)00359-9","article-title":"Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial","volume":"11","author":"Maher","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026022011472288100_hcaf260-B76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2014-eular.2342","article-title":"OP0037 pulsed cyclophosphamide in the treatment of rheumatoid arthritis-related interstitial lung disease (RA-ILD)","volume":"73","author":"Kelly","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026022011472288100_hcaf260-B77","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3899\/jrheum.150674","article-title":"Leflunomide use and risk of lung disease in rheumatoid arthritis: a systematic literature review and metaanalysis of randomized controlled trials","volume":"43","author":"Conway","year":"2016","journal-title":"J Rheumatol"},{"key":"2026022011472288100_hcaf260-B78","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026022011472288100_hcaf260-B79","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10067-023-06623-7","article-title":"Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial","volume":"42","author":"Matteson","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026022011472288100_hcaf260-B80","first-page":"4534","article-title":"Randomized, double blinded, placebo-controlled, phase 2 study of safety, tolerability and efficacy of pirfenidone in patients with rheumatoid arthritis interstitial lung disease","volume":"60 suppl 66","author":"Rosas","year":"2022","journal-title":"Eur Respir J"},{"key":"2026022011472288100_hcaf260-B81","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001580","article-title":"Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)","volume":"10","author":"Maher","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"2026022011472288100_hcaf260-B82","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12890-021-01595-3","article-title":"Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis","volume":"21","author":"Sugino","year":"2021","journal-title":"BMC Pulm Med"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcaf260\/65041852\/hcaf260.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/1\/7\/65041852\/hcaf260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/1\/7\/65041852\/hcaf260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:47:39Z","timestamp":1771606059000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/119\/1\/7\/8306835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,30]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcaf260","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,10,30]]}}}